| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |